NCT00965666View on ClinicalTrials.gov

Pilot Study of Etanercept (Enbrel) in Children With Fanconi Anemia

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions
Fanconi Anemia
Interventions
DRUG

Etanercept

All qualified subjects receive 24 weekly subcutaneous injections of Etanercept.

Trial Locations (1)

45229-3039

Cincinnati Children's Hospital Medical Center, Cincinnati

Sponsors

Collaborators (1)

Amgen
All Listed Sponsors
collaborator

Amgen

INDUSTRY

lead

Children's Hospital Medical Center, Cincinnati

OTHER

NCT00965666 - Pilot Study of Etanercept (Enbrel) in Children With Fanconi Anemia | Biotech Hunter | Biotech Hunter